Multiparametric MRI in the PSA Screening Era

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  George, Arvin K ^a   Pinto, Peter A ^a   Rais Bahrami, Soroush ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER THERAPY; CLINICAL TRIAL (TOPIC); DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; HUMAN; IMAGE ANALYSIS; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; PATIENT IDENTIFICATION; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW (TOPIC); TRANSRECTAL ULTRASONOGRAPHY; TREATMENT INDICATION; BLOOD; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; MALE; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; PROSTATIC NEOPLASMS; REPRODUCIBILITY;

EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIMODAL IMAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84929296596     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/465816     Document Type: Review

References (44)

1. http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-key-statistics.
2. B. K. Edwards, A. M. Noone, A. B. Mariotto, et al., "Annual report to the nation on the status of cancer 1975-2010, featuring prevalence of comorbidity and impact on survival among personswith lung, colorectal, breast, or prostate cancer, " Cancer, vol. 120, no. 9, pp. 1290-1314, 2014.
3. V. A. Moyer, M. L. LeFevre, A. L. Siu, et al., "Screening for prostate cancer: US Preventive Services Task Force recommendation statement, " Annals of InternalMedicine, vol. 157, no. 2, pp. 120-134, 2012.
4. M. S. Cohen, R. S. Hanley, T. Kurteva, et al., "Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system the Lahey Clinic Medical Center experience and international meta-analysis, " European Urology, vol. 54, no. 2, pp. 371-381, 2008.
5. S. Rais-Bahrami, M. M. Siddiqui, B. Turkbey, et al., "Utility of multiparametric mri suspicion scores for detecting prostate cancer, " Journal of Urology, vol. 190, no. 5, pp. 1721-1727, 2013.
6. S. Rais-Bahrami, M. M. Siddiqui, S. Vourganti, et al., "Diagnostic value of biparametricMRI as an adjunct to PSA-based detection of prostate cancer in men without prior biopsies, " BJU International, 2014.
7. J. Haffner, L. Lemaitre, P. Puech, et al., "Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection, " BJU International, vol. 108, no. 8, part 2, pp. E171-E178, 2011.
8. D. Volkin, B. Turkbey, A. N. Hoang, and et al, "Multiparametric MRI and subsequent MR/ultrasound fusion-guided biopsy increase the detection of anteriorly located prostate cancers, " BJU International, 2014.
9. C. W. Hong, S. Rais-Bahrami, A. Walton Diaz, et al., "Comparison of MR-US fusion-guided prostate biopsies obtained from axial and sagittal approaches, " BJU International, 2014.
10. A. Villers, P. Puech, D. Mouton, X. Leroy, C. Ballereau, and L. Lemaitre, "Dynamic contrast enhance, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting prostate volume: correlation with radical prostatectomy findings, " Journal of Urology, vol. 176, no. 6, pp. 2432-2437, 2006.
11. N. A. Shakir, A. K. George, M. M. Siddiqui, et al., "Identification of threshold prostate-specific antigen levels to optimize the detection of clinically significant prostate cancer by MRI/US fusion guided biopsy, " The Journal of Urology, 2014.
12. A. de la Taille, P. Antiphon, L. Salomon, et al., "Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate, " Urology, vol. 61, no. 6, pp. 1181-1186, 2003.
13. J. W. Nix, B. Turkbey, A. Hoang, et al., "Very distal apical prostate tumours: identification onmultiparametric MRI at 3 Tesla, " BJU International, vol. 110, no. 11, part B, pp. E694-E700, 2012.
14. K. N. Nagel, M. G. Schouten, T. Hambrock, et al., "Differentiation of prostatitis and prostate cancer by using diffusionweightedMRimaging and MR-guided biopsy at 3 T, " Radiology, vol. 267, no. 1, pp. 164-172, 2013.
15. A. Walton-Diaz, A. N. Hoang, B. Turkbey, et al., "Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?" Journal of Urology, vol. 190, pp. 2020-2025, 2013.
16. S. Vourganti, A. Rastinehad, N. K. Yerramet al., "Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies, " Journal of Urology, vol. 188, no. 6, pp. 2152-2157, 2012.
17. B. K. Park, H. M. Lee, C. K. Kim, H. Y. Choi, and J. W. Park, "Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three tesla before rebiopsy, " Investigative Radiology, vol. 43, no. 11, pp. 789-793, 2008.
18. T. Hambrock, D. M. Somford, C. Hoeks, et al., "Magnetic resonance imaging guided prostate biopsy in med with repeat negative biopsies and increased prostate specific antigen, " Journal of Urology, vol. 183, no. 2, pp. 520-528, 2010.
19. M. Abd-Alazeez, A. Hu, M. Arya, et al., "The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level-can it rule out clinically significant prostate cancer?" Urologic Oncology: Seminars and Original Investigations, vol. 32, no. 1, pp. 45. e17-45. e21, 2014.
20. M. M. Siddiqui, S. Rais-Bahrami, H. Truong, et al., "Magnetic resonance imaging/Ultrasound fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy, " European Urology, vol. 64, no. 5, pp. 713-719, 2013.
21. A. R. Rastinehad, B. Turkbey, S. S. Salami, et al., "Improving detection of clinically significant prostate cancer: MRI/TRUS fusion-guided prostate biopsy, " Journal of Urology, vol. 191, no. 6, pp. 1749-1754, 2014.
22. C. M. Moore, N. L. Robertson, N. Arsanious, et al., "Imageguided prostate biopsy using magnetic resonance imagingderived targets: a systematic review, " European Urology, vol. 63, no. 1, pp. 125-140, 2013.
23. F. Lista, H. Gimbernat, F. Caceres, J. M. Rodriguez-Barbero, E. Castillo, and J. C. Angulo, "Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer cand idates for radical prostatectomy, " Actas Urologicas Espanolas, vol. 38, no. 5, pp. 290-297, 2014.
24. J. Otto, G. Thormer, M. Seiwerts, et al., "Value of endorectal magnetic resonance imaging at 3T for the local staging of prostate cancer, " Rof o, vol. 186, no. 8, pp. 795-802, 2014.
25. D. Raskolnikov, A. K. George, and S. Rais-Bahrami, "Multiparametric magnetic resonance imaging and image-guided biopsy to detect seminal vesicle invasion by prostate cancer, " Journal of Endourology, 2014.
26. F. N. Soylu, Y. Peng, Y. Jiang, et al., "Seminal vesicle invasion in prostate cancer: evaluation by usingmultiparametric endorectal MR imaging, " Radiology, vol. 267, no. 3, pp. 797-806, 2013.
27. D. M. Somford, E. H. Hamoen, J. J. Futterer, et al., "The predictive value of endorectal 3 Teslamultiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate, and high risk prostate cancer, " The Journal of Urology, vol. 190, no. 5, pp. 1728-1734, 2013.
28. B. H. Park, H. G. Jeon, B. C. Jeong, et al., "Influence of magnetic resonance imaging in the decision to preserve or resect neurovascular bundles at robotic assisted laparoscopic radical prostatectomy, " The Journal of Urology, vol. 192, no. 1, pp. 82-88, 2014.
29. B. G. Mueller, W. van den Bos, P. A. Pinto, et al., "Imagingmodalities in focal therapy: patient selection, treatment guidance, and follow-up, " Current Opinion in Urology, vol. 24, no. 3, pp. 218-224, 2014.
30. H. U. Ahmed, O. Akin, J. A. Coleman, et al., "Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer, " BJU International, vol. 109, no. 11, pp. 1636-1647, 2012.
31. C. Roy, F. Foudi, J. Charton, et al., "Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or externalbeam radiotherapy, " The American Journal of Roentgenology, vol. 200, no. 4, pp. W361-W368, 2013.
32. E. Rud, E. Baco, D. Lien, et al., "Detection of radiorecurrent prostate cancer using diffusion-weighted imaging and targeted biopsies, " American Journal of Roentgenology, vol. 202, no. 3, pp. W241-W246, 2014.
33. K. Kitajima, RC. Murphy, M. A. Nathan, et al., "Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil, " Journal of Nuclear Medicine, vol. 55, no. 2, pp. 223-232, 2014.
34. N. Betrouni, P. Colin, P. Puech, A. Villers, and S. Mordon, "An image guided treatment platform for prostate cancer photodynamic therapy, " in Proceedings of the 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 13), pp. 370-373, Osaka, Japan, July 2013.
35. A. Partanen, N. K. Yerram, H. Trivedi, et al., "Magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI-based moulds, " BJU International, vol. 112, no. 4, pp. 508-516, 2013.
36. B. Turkbey, H. Mani, O. Aras, et al., "Prostate cancer: can multiparametric mr imaging help identify patients who are cand idates for active surveillance?" Radiology, vol. 268, no. 1, pp. 144-152, 2013.
37. L. Stamatakis, M. M. Siddiqui, J. Nix, et al., "Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance in men with prostate cancer, " Cancer, vol. 119, no. 18, pp. 3359-3366, 2013.
38. S. Rais-Bahrami, B. Turkbey, A. R. Rastinehad, et al., "Natural history of small index lesions suspicious for prostate cancer on multi-parametric MRI: recommendations for interval imaging follow-up, " Diagnostic and Interventional Radiology, vol. 20, no. 4, pp. 293-298, 2014.
39. L. M. Johnson, J. T. Rothwax, B. Turkbey, et al., "Multiparametric magnetic resonance imaging of the prostate AIDS to detect lesion progression, " Journal of Computer Assisted Tomography, vol. 38, no. 4, pp. 565-567, 2014.
40. D. Raskolnikov, S. Rais-Bahrami, A. K. George, et al., "The role of image-guided biopsy targeting in patients with atypical small acinar proliferation, " The Journal of Urology, 2014.
41. F. D. Birkhauser, U. E. Studer, J. M. Froehlich, et al., "Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer, " European Urology, vol. 64, no. 6, pp. 953-960, 2013.
42. L. A. Heijnen, D. M. Lambregts, M. H. Martens, et al., "Performance of gadof osveset-enhanced MRI for staging rectal cancer nodes: can the initial promising results be reproduced?" European Urology, vol. 24, no. 2, pp. 371-379, 2014.
43. M. Hartenbach, S. Hartenbach, W. Bechtlof f, et al., "Combined PET/MRI improves diagnostic accuracy in patients with prostate cancer: a diagnostic trial, " Clinical Cancer Research, vol. 20, no. 12, pp. 3244-3253, 2014.
44. M. Valerio, A. E. Bosaily, M. Emberton, and H. U. Ahmed, "Defining the level of evidence for technology adoption in the localized prostate cancer pathway, " Urologic Oncology, vol. 32, no. 6, pp. 924-930, 2014.